TY - GEN
T1 - SpikeVox
T2 - 21st IEEE Biomedical Circuits and Systems, BioCAS 2025
AU - Putra, Rachmad Vidya Wicaksana
AU - Nair, Aadithyan Rajesh
AU - Shafique, Muhammad
N1 - Publisher Copyright:
© 2025 IEEE.
PY - 2025
Y1 - 2025
N2 - Speech disorders can significantly affect the patients' capability to communicate, learn, and socialize. However, existing speech therapy solutions (e.g., therapist or tools) are still limited and costly, hence such solutions remain inadequate for serving millions of patients worldwide. To address this, state-of-the-art methods employ neural network (NN) algorithms to help accurately detecting speech disorders. However, these methods do not provide therapy recommendation as feedback, hence providing partial solution for patients. Moreover, these methods incur high energy consumption due to their complex and resource-intensive NN processing, hence hindering their deployments on low-power/energy platforms (e.g., smartphones). Toward this, we propose SpikeVox, a novel framework for enabling energy-efficient speech therapy solutions through spike-driven generative language model. Specifically, SpikeVox employs a speech recognition module to perform highly accurate speech-to-text conversion; leverages a spike-driven generative language model to efficiently perform pattern analysis for speech disorder detection and generates suitable exercises for therapy; provides guidance on correct pronunciation as feedback; as well as utilizes the REST API to enable seamless interaction for users. Experimental results demonstrate that SpikeVox achieves 88% confidence level on average in speech disorder recognition, while providing a complete feedback for therapy exercises. Therefore, SpikeVox provides a comprehensive framework for energyefficient speech therapy solutions, and potentially addresses the significant global speech therapy access gap.
AB - Speech disorders can significantly affect the patients' capability to communicate, learn, and socialize. However, existing speech therapy solutions (e.g., therapist or tools) are still limited and costly, hence such solutions remain inadequate for serving millions of patients worldwide. To address this, state-of-the-art methods employ neural network (NN) algorithms to help accurately detecting speech disorders. However, these methods do not provide therapy recommendation as feedback, hence providing partial solution for patients. Moreover, these methods incur high energy consumption due to their complex and resource-intensive NN processing, hence hindering their deployments on low-power/energy platforms (e.g., smartphones). Toward this, we propose SpikeVox, a novel framework for enabling energy-efficient speech therapy solutions through spike-driven generative language model. Specifically, SpikeVox employs a speech recognition module to perform highly accurate speech-to-text conversion; leverages a spike-driven generative language model to efficiently perform pattern analysis for speech disorder detection and generates suitable exercises for therapy; provides guidance on correct pronunciation as feedback; as well as utilizes the REST API to enable seamless interaction for users. Experimental results demonstrate that SpikeVox achieves 88% confidence level on average in speech disorder recognition, while providing a complete feedback for therapy exercises. Therefore, SpikeVox provides a comprehensive framework for energyefficient speech therapy solutions, and potentially addresses the significant global speech therapy access gap.
KW - generative language models
KW - low-power/energy solutions
KW - machine learning
KW - Speech therapy
KW - spiking neural networks
UR - https://www.scopus.com/pages/publications/105033227074
U2 - 10.1109/BioCAS67066.2025.00028
DO - 10.1109/BioCAS67066.2025.00028
M3 - Conference contribution
AN - SCOPUS:105033227074
T3 - Proceedings - 21st IEEE Biomedical Circuits and Systems, BioCAS 2025
SP - 81
EP - 85
BT - Proceedings - 21st IEEE Biomedical Circuits and Systems, BioCAS 2025
PB - Institute of Electrical and Electronics Engineers Inc.
Y2 - 16 October 2025 through 18 October 2025
ER -